The availability of genetic testing for BRCA mutations is potentially valuable in surgical decision making for newly diagnosed breast cancer patients, as approximately one-half of patients who are discovered to carry BRCA1/2 mutations are likely to choose bilateral mastectomy compared to only one-fourth of non-carriers [34]. Here, BRCA1 is linked to breast carcinoma.